Jazz Pharmaceuticals PLC (JAZZ.OQ)
Fri, Mar 2 2018
BRIEF-Jazz Announces FDA Acceptance Of NDA For Solriamfetol For Excessive Sleepiness Associated With Narcolepsy Or Obstructive Sleep Apnea
* JAZZ PHARMACEUTICALS ANNOUNCES FDA ACCEPTANCE OF NDA FOR SOLRIAMFETOL (JZP-110) FOR EXCESSIVE SLEEPINESS ASSOCIATED WITH NARCOLEPSY OR OBSTRUCTIVE SLEEP APNEA
* JAZZ PHARMACEUTICALS ANNOUNCES FULL YEAR AND FOURTH QUARTER 2017 FINANCIAL RESULTS
* JAZZ PHARMACEUTICALS ANNOUNCES FIRST PATIENT ENROLLED IN PHASE 2 CLINICAL TRIAL EVALUATING DEFIBROTIDE FOR THE PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE Source text for Eikon: Further company coverage:
* JAZZ PHARMACEUTICALS SUBMITS NEW DRUG APPLICATION FOR SOLRIAMFETOL (JZP-110) FOR EXCESSIVE SLEEPINESS ASSOCIATED WITH NARCOLEPSY AND OBSTRUCTIVE SLEEP APNEA
Dec 15 A Pennsylvania man pleaded guilty on Friday to charges that he traded on confidential, inside information that a former Celator Pharmaceuticals Inc employee supplied him, including that the company now owned by Jazz Pharmaceuticals Plc was planning to be acquired.
BRIEF-Jazz Pharmaceuticals Announces Appointment Of Daniel Swisher As President And Chief Operating Officer
* JAZZ PHARMACEUTICALS ANNOUNCES APPOINTMENT OF DANIEL SWISHER AS PRESIDENT AND CHIEF OPERATING OFFICER Source text for Eikon: Further company coverage: (Bangalore.firstname.lastname@example.org)
* Jazz pharmaceuticals announces third quarter 2017 financial results
* Jazz Pharmaceuticals submits Vyxeos™ Marketing Authorization Application to European Medicines Agency for treatment of certain types of high-risk acute myeloid leukemia Source text for Eikon: Further company coverage:
- Does Avadel Pharmaceuticals Have The Potential To 10-Double?
- 3 Things In Biotech, March 4, 2018: Biogen Forfeits, Regeneron Advances, Jazz Isn't Tired Yet
- Your Daily Pharma Scoop: Conatus Rallies, Ionis Data, Reata's Omaveloxolone Fails In Mid-Stage Study
- ROTY Volume 1 Edition 83: Thank You For Your Patience - Launch Day Has Arrived!
- Jazz Pharmaceuticals, Inc. 2017 Q4 - Results - Earnings Call Slides
- Jazz Pharmaceuticals Plc (JAZZ) Q4 2017 Results - Earnings Call Transcript